We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
376
DELISTED
NuVasive, Inc.
NUVA
| $13.8M | 0.06% |
+203,586
| New | +$13.9M |
|
377
Abercrombie & Fitch
ANF
$4.45B
| $13.8M | 0.06% |
296,184
+60,578
| +26% | +$2.44M |
|
378
RadNet
RDNT
$4.93B
| $13.8M | 0.06% |
408,200
+43,100
| +12% | +$1.14M |
|
|
NARI
379
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $13.4M | 0.06% |
+144,023
| New | +$14M |
|
380
Medpace
MEDP
$16.1B
| $13.4M | 0.06% |
75,951
-37,439
| -33% | -$6.46M |
|
381
ZIM Integrated Shipping Services
ZIM
$2.98B
| $13.4M | 0.06% |
+298,500
| New | +$11.5M |
|
382
Vertex Pharmaceuticals
VRTX
$122B
| $13.4M | 0.06% |
66,500
-597,473
| -90% | -$125M |
|
383
Floor & Decor
FND
$5.98B
| $13.4M | 0.06% |
126,400
-28,790
| -19% | -$2.99M |
|
384
Crinetics Pharmaceuticals
CRNX
$8.85B
| $13.3M | 0.06% |
708,133
-566,867
| -44% | -$9.96M |
|
385
NetEase
NTES
$84.4B
| $13.3M | 0.06% |
+115,700
| New | +$12.7M |
|
|
SAGE
386
DELISTED
Sage Therapeutics
SAGE
| $13M | 0.06% |
228,200
-105,500
| -32% | -$7.46M |
|
387
Cheniere Energy
LNG
$54.1B
| $13M | 0.06% |
+149,371
| New | +$12.1M |
|
|
WPF
388
DELISTED
Foley Trasimene Acquisition Corp.
WPF
| $12.9M | 0.06% |
1,325,000
-2,275,000
| -63% | -$23.1M |
|
389
Ally Financial
ALLY
$13.2B
| $12.9M | 0.06% |
258,700
-71,500
| -22% | -$3.67M |
|
390
CALL
Uber
UBER
$143B
| $12.8M | 0.06% |
255,000
-645,000
| -72% | -$33.7M |
|
391
CME Group
CME
$96.1B
| $12.8M | 0.06% |
60,032
| – | – |
|
392
TransAlta
TAC
$4.06B
| $12.7M | 0.06% |
1,275,000
+164,600
| +15% | +$1.59M |
|
393
Genius Sports
GENI
$1.87B
| $12.7M | 0.06% |
+675,580
| New | +$13.4M |
|
394
Adicet Bio
ACET
$84.7M
| $12.5M | 0.06% |
75,938
+10,432
| +16% | +$2.12M |
|
395
Pool Corp
POOL
$6.95B
| $12.4M | 0.06% |
+26,972
| New | +$11.4M |
|
396
Sibanye-Stillwater
SBSW
$6.43B
| $12.3M | 0.06% |
738,200
+78,600
| +12% | +$1.46M |
|
397
Oshkosh
OSK
$8.82B
| $12.3M | 0.06% |
99,000
+40,200
| +68% | +$5.08M |
|
398
Linde
LIN
$235B
| $12.3M | 0.06% |
+42,474
| New | +$12.4M |
|
|
HSKA
399
DELISTED
Heska Corp
HSKA
| $12.3M | 0.06% |
53,401
-3,256
| -6% | -$639K |
|
400
SBA Communications
SBAC
$19.3B
| $12.2M | 0.05% |
+38,200
| New | +$11.5M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.